Hyperfine Research
在场
Hyperfine Research 是一家在股票代码 HYPR (US) 下上市的公司。
高管
查看带有其 11 名主要高管的组织结构图
Hyperfine Research 搜索最多的简介
- Maria Sainz, President and Chief Executive Officer
- Ruth Fattori, Director
- Scott Huennekens As, Executive Chairman of the Board
高管在Hyperfine Research变化
- Edmond Knopp 曾任 Senior Medical Director, 现升职为 Vice President, Medical Affairs (新闻发布的2023十月11号).
创建提醒
跟踪 Hyperfine Research 的高管变动
生物技术
Hyperfine Research 拥有 2,284 家竞争者，其中包括 Lonza (瑞士)、Eurofins (卢森堡) 和 Adaptive Phage Therapeutics (美国(美洲))。
Popular M&A news in 生物技术
- Karius 刚刚宣布为 100 筹款数百万美元。 (公布2024五月3号).
- Transcarent 刚刚宣布为 126 筹款数百万美元。 (公布2024五月2号).
- WindRose Health Investors has announced the acquisition of SubjectWell (公布2024五月2号).
生物技术 行业的其他推荐联系人
消息
Hyperfine Research 的最新新闻稿
- First Alzheimer’s Patients Enrolled in CARE PMR Study
- Hyperfine, Inc. Takes the Stage at ISMRM with 17 Abstracts
- Hyperfine, Inc. Presents Swoop® System to The Princess Royal
- Hyperfine, Inc. & Athletic Heart Brain Health Collaboration
- Swoop® System Data Presented at ISC 2024 & ACTION PMR Update
- Hyperfine, Inc. Launches AI-powered Brain Imaging Software
- Hyperfine, Inc. Announces Presentations at RSNA 2023
- Portable MR Brain Imaging System and ABI in ECMO Patients
- Hyperfine, Inc. Promotes Two Clinical Affairs Executives
- Hyperfine, Inc. FDA Clearance for Updated AI-powered Software
- View more press releases Close
通过电子邮件
